Latest Posts › EU

Share:

New Guidance: Inside Information Disclosure by Listed Biotech Companies in Belgium

The Development: Belgium's financial regulator, the Financial Services and Markets Authority ("FSMA"), published a recent opinion on "Considerations and good practices with respect to inside information disclosures by listed...more

COVID-19 Key EU Developments, Policy & Regulatory Update No. 26

This regular alert covers key regulatory EU developments related to the COVID-19 situation. It does not purport to provide an exhaustive overview of developments and contains no analysis or opinion. LATEST KEY DEVELOPMENTS...more

COVID-19 Key EU Developments, Policy & Regulatory Update No. 24

This regular update (no. 24 | 13 October 2020) covers key regulatory EU developments related to the evolving COVID-19 situation (Antitrust & State Aid; Trade/Export Controls; Medicines, Medical Devices and Personal Protective...more

COVID-19 Key EU Developments, Policy & Regulatory Update No. 25

This regular alert covers key regulatory EU developments related to the COVID-19 situation. It does not purport to provide an exhaustive overview of developments and contains no analysis or opinion. LATEST KEY DEVELOPMENTS...more

COVID-19 Key EU Developments, Policy & Regulatory Update No. 23

This regular update (no. 23 | 29 September 2020) covers key regulatory EU developments related to the evolving COVID-19 situation (Antitrust & State Aid; Trade/Export Controls; Medicines, Medical Devices and Personal...more

COVID-19 Key EU Developments, Policy & Regulatory Update No. 22

This regular update (no. 22 | 22 September 2020) covers key regulatory EU developments related to the evolving COVID-19 situation (Antitrust & State Aid; Trade/Export Controls; Medicines, Medical Devices and Personal...more

COVID-19 Key EU Developments, Policy & Regulatory Update No. 20

This regular alert covers key regulatory EU developments related to the COVID-19 situation. It does not purport to provide an exhaustive overview of developments and contains no analysis or opinion. ...more

Trade Controls in the EU: COVID-19 Measures at a Glance

In response to the novel coronavirus ("COVID-19") pandemic, the European Union ("EU"), various Member States and the United Kingdom have adopted trade control measures aimed at avoiding shortages and ensuring the availability...more

COVID-19 Key EU Developments, Policy & Regulatory Update No. 5

LATEST KEY DEVELOPMENTS Competition & State Aid • EU approves Member State measures to support the economy • Austria requests EU to suspend State aid rules • Eurogroup Report on the comprehensive economic...more

COVID-19 Key EU Developments, Policy & Regulatory Update No. 4

LATEST KEY DEVELOPMENTS Competition & State Aid • Proposed expansion of State aid Temporary Framework to recapitalization • EU approves Member State measures to support the economy Trade / Export Controls...more

COVID-19 Key EU Developments, Policy & Regulatory Update No. 3

LATEST KEY DEVELOPMENTS Competition & State Aid • Guidance on allowing limited cooperation among businesses • EU approves Member State measures to support the economy Trade / Export Controls • Commission...more

COVID-19 Key EU Developments, Policy & Regulatory Update No. 2

LATEST KEY DEVELOPMENTS Competition & State Aid • DG COMP COVID-19 website and mailbox for informal guidance • Extension of State aid Temporary Framework • Public short-term export credit insurance available...more

COVID-19 Key EU Developments, Policy & Regulatory Updated No. 1

Competition & State Aid • Delay of merger notifications • State aid procedures fast-tracked • Communication on Temporary State Aid Framework adopted Foreign direct investment control • Commission urges vigilance in...more

The EU Pharma Incentives Review—Two Studies and a Legislative Proposal Released

The Situation: On May 28 and 29, 2018, the European Commission ("Commission") published two studies aimed at examining the economic and legal impacts of the European Union's regime on Supplementary Protection Certificates...more

France Simplifies Local Medical Device Regulations and Sets Precedent for Other Member States

On April 26, 2018, the French administrative Supreme Court (Conseil d'Etat) issued a ruling that annulled Decree 2016-1716 of December 13, 2016 ("2016 Decree") related to the summary of characteristics for medical devices....more

Food, Dietary Supplement & Cosmetics Update | Vol. V, Issue 1

Top News - FDA Announces Intention to Not Enforce Certain FSMA Final Rules Provisions - On January 4, 2018, the U.S. Food and Drug Administration ("FDA") issued a guidance announcing that it does not intend to enforce...more

Food, Dietary Supplement & Cosmetics Update | Vol. IV, Issue 7

USDA Inspector General Recommends Reform of AMS Organic Program for Imports - The USDA Inspector General ("IG") reviewed the Agricultural Marketing Service's ("AMS") process used in determining whether exporting...more

Food, Dietary Supplement & Cosmetics Update | Vol. IV, Issue 6

TOP NEWS - FDA Proposes New Compliance Dates for the Water Provisions of the Produce Safety Final Rule - On September 13, 2017, the Food and Drug Administration issued a proposed rule to extend, for covered produce...more

Food, Dietary Supplement & Cosmetics Update | Vol. IV, Issue 5

On June 13, 2017, FDA delayed the compliance date for the Nutrition Facts and Supplement Facts Label and Serving Size final rules, providing additional time for implementation. The rules were finalized in May 2016 and...more

EMA Calls for Public Consultation on Clinical Trial Protocol, Pharmaceutical & Medical Device Update, Vol. IV, Issue III

June 2017 The EMA has opened for public consultation a draft guideline for the notification of serious breaches of the Clinical Trial Protocol (Regulation (EU) No 536/2014)...more

EMA Green Lights New EudraVigilance System for Adverse Reactions, Pharmaceutical & Medical Device Update, Vol. IV, Issue III

On May 22, 2017, the European Medicines Agency ("EMA") announced the full functionality of the new EudraVigilance system for the collection and monitoring of suspected adverse reactions with medicinal products that are...more

Guidance for European MA Holders to Prepare for Brexit, Pharmaceutical & Medical Device Update, Vol. IV, Issue III

The EMA has published a Q&A guidance for marketing authorization ("MA") holders of centrally authorized medicinal products to prepare for the United Kingdom's withdrawal from the European Union. This follows an earlier notice...more

EU Medical Device Regulation 2017/745 and In Vitro Diagnostic Regulation 2017/746, Pharmaceutical & Medical Device Update, Vol....

Following their adoption by the European Parliament in April 2017, the final versions of the Medical Devices Regulation ("MDR") and In Vitro Diagnostic Regulation ("IVDR") were published in the Official Journal of the...more

European Food Safety Authority Launches Public Consultation on the Risk Assessment of GMO at Low Level

The European Food Safety Authority ("EFSA") has launched a public consultation on a draft guidance document on the risk assessment of genetically modified organisms ("GMOs") present at low levels in food and feed material....more

The European Commission Amends Plastic Food Contact Materials Legislation

On April 28, 2017, the European Commission issued Regulation 2017/752, amending Regulation 10/2011 on plastic materials and articles intended to come into contact with food...more

129 Results
 / 
View per page
Page: of 6

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide